This is going to start creeping upwards.. in the lead up to adult trials results, I suspect we edge towards the 50 cent mark. good results (expected), to take us to the 60-65 cent mark. fda submission 70-75 cent mark. slight retrace to the 58-65 cent mark as we wait. then $1.25-$1.50 shortly after fda approval, edging towards the $2.00 mark upon announcements relating to MOU's/Contracts.
Australia-China Biotech Invest 2017, page-12
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAP (ASX) to my watchlist
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online